UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047499
Receipt number R000054161
Scientific Title A multicenter study of the efficacy of different preoperative drainage methods and their impact on surgery for hilar cholangiocarcinoma using real clinical data.
Date of disclosure of the study information 2022/04/18
Last modified on 2023/04/17 18:59:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter study of the efficacy of different preoperative drainage methods and their impact on surgery for hilar cholangiocarcinoma using real clinical data.

Acronym

POD study

Scientific Title

A multicenter study of the efficacy of different preoperative drainage methods and their impact on surgery for hilar cholangiocarcinoma using real clinical data.

Scientific Title:Acronym

POD study

Region

Japan


Condition

Condition

Hilar cholangiocarcinoma

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The goal is to clarify the consensus on preoperative biliary drainage for cholangiocarcinoma of the hilar region, as well as to establish the indications and methods of preoperative biliary drainage.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Frequency of cholangitis and stent obstruction by preoperative biliary drainage method

Key secondary outcomes

Operative blood loss, R0 operative rate, incidence of infectious complications, biliary fistula, pancreatic fistula, etc., 90-day mortality rate.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with hilar cholangiocarcinoma who underwent surgical radical surgery with preoperative biliary drainage from January 2017 to December 2020 at a Japanese Biliary Society-approved teaching facility.
1. patients who do not refuse to participate in the study of their own free will or that of their family members
2. patients who are 20 years of age or older at the time of examination and treatment

Key exclusion criteria

1. patients who refuse to participate in the research by themselves or their family members
2. Other patients deemed inappropriate by the principal investigator or principal study investigator

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Yoshiki
Middle name
Last name Hirooka

Organization

Fujita Health University

Division name

Department of Gastroenterology and Hepatology

Zip code

470-1192

Address

1-98, Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi

TEL

+81562932324

Email

yoshiki.hirooka@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Senju
Middle name
Last name Hashimoto

Organization

Fujita Health University

Division name

Department of Gastroenterology and Hepatology

Zip code

470-1192

Address

1-98, Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi

TEL

+81562932324

Homepage URL


Email

hsenju@fujita-hu.ac.jp


Sponsor or person

Institute

Japan Biliary Association

Institute

Department

Personal name



Funding Source

Organization

Japan Biliary Association

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fujita Health University

Address

1-98, Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi

Tel

+81562932865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

500

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 03 Month 01 Day

Date of IRB

2022 Year 04 Month 13 Day

Anticipated trial start date

2022 Year 04 Month 20 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2022 Year 04 Month 15 Day

Last modified on

2023 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054161


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name